Customer Service
Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200
Need Technical Assistance With this Website?
Send an email to IIR's Web Department
| Day Two| Wednesday January 28th, 2009 | | 8:15 | Morning fCoffee Hosted by:  | | 9:00 | Chairperson’s Welcome
Robert Scott-Edwards, President, ICON CENTRAL LABORATORIES
Cynthia Lindemann, Associate CDS Consultant/Central Laboratory Coordinator, Clinical Diagnostic Services, ELI LILLY & COMPANY | | 9:15 | Strengthening the Sponsor / Vendor / Site Relationship. What Do Sites Really Think? Site Survey- Sites’ Perspective to Improve Efficiency and Quality in Clinical Trials
Gary Albert, Manager Clinical Operations, ALNYLAM PHARMACEUTICALS
William Smith, President, Clinical Research, NEW ORLEANS CENTER FOR CLINICAL RESEARCH INVITED invited
Clare O'Sullivan, General Manager, ICON CENTRAL LABORATORIES, Dublin | | 10:00 | INSPIRATIONAL KEYNOTE | | |  Incredible Change: Overcome your Partnering Obstacles with the “Hulk”
Overcome fear and maximizing your own personal power! Hear how he has dealt with adversity and how he came from nothing to overcome every obstacle he has encountered! Lou Ferrigno, “THE INCREDIBLE HULK” | | 10:45 | NETWORKING BREAK KEYNOTE MEET AND GREET | | 11:30 | Sample Management: Tracking Global Lab Samples to Ensure you Get the Data
Adam Ruskin, Director, MAXYGEN PHARMACEUTICALS | | PANEL DISCUSSION | | 12:00 | Comparing Approaches: Preferred Providers vs Competitive Bidding, What is your Best Choice?
Panelists:
Diane Stinson, External Services Group, MERCK & COMPANY
Jim Meringolo, Vice President, ICON CENTRAL LABORATORIES
Roberto Vaccaro, Senior Manager, Electronic Data Services
R&D Strategic Sourcing & Procurement, AMGEN | | 12:30 | Networking Luncheon in Exhibit Hall | | Track A: Central Lab Relationship Development | | 1:30 | Chairperson’s Opening Remarks Stephanie Talbott, Vice President, Global Business Development, ICON CENTRAL LABORATORIES
| | MCC CENTRAL LABORATORY METRICS VERSION 1.1 CASE STUDY AND PANEL | | 1:35 | Overview of Metrics: Definition Refinement & Update from the Central Lab MCC Initiative
Sue Hwang, Senior Manager, R&D Global Strategic Sourcing, AMGEN
Cynthia Lindemann, CDS Consultant, Central Laboratory ,Coordinator, Clinical Diagnostic Services, ELI LILLY & COMPANY Alissa Kerry, Sr. Manager, Business Process Measurements Covance Central Laboratory | | 2:15 | PANEL DISCUSSION Reducing Costs at Investigator Sites through Process Improvement
Jennifer Christie, Master Black Belt, COVANCE CENTRAL LABORATORIES SERVICES
Jonathan Koch, Vice President, Global Clinical Trial Management & Operations, COVANCE CENTRAL LABORATORIES SERVICES TBA JOHNSON & JOHNSON | | | 3:00 | OPEN SESSION | | 3:30 | Conference Concludes | | Track B: Standardization in Imaging Studies | | 1:30 | Chairperson’s Opening Remarks
David Rauh, Clinical Diagnostic Services Imaging Management, ELI LILLY & COMPANY | | 1:35 | Charter Development and Industry Standardization with FDA/ PhRMA
Vahe Ghahraman, PhD, Associate Director, RAC, DYAX CORPORATION | | 2:15 | Building the Imaging Lexicon for Rate Cards to Improve Industry Consistency
P. David Mozley, MD, Senior Director, MERCK & COMPANY | | 3:00 | Imaging Regulatory Environment Shift Strategies
George Mills, PhD, Vice President, Medical Imaging Consulting, Perceptive Informatics, PAREXEL INTERNATIONAL
Beth Sabatino, Outsourcing Manager, BRISTOL MYERS SQUIB | | 3:30 | Conference Concludes | | Track C: Improving and Standardizing ECG and Cardiac Safety Studies | | 1:30 | Chairperson’s Opening Remarks | | EXTENDED SESSION | | 1:35 | Working Together to Develop Biomarkers for Safety Monitoring and Surrogate Endpoints
Samir Khleif, Head, Cancer Vaccine Section Investigator, NATIONAL CANCER INSTITUTE, NIH Wendy R. Sanhai, PhD, Senior Scientific Advisor, Office of the Commissioner, FDA *FDA Session* Dr. Bill Wheeler, MD, FACC, Global Medical Director, Centralized Cardiac Sevices, MDS PHARMA SERVICES
Dr. Patrice Hugo Vice-President of Scientific Affairs, MDS PHARMA SERVICES | | 3:00 | Methods to Mitigate the Potentially Distorting Effect of Heart Rate in QT Analyses
Lawrence Z. Satin, MD, FACC, Chief Medical Officer, CARDIOCORE TBA SHIRE PHARMACEUTICALS | | 3:30 | Conference Concludes | | | |
|
